| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Apr―16 |
Signal Monitoring for Adverse Events Following Immunisation with COVID-19 Vaccines During the SARS-CoV-2 Pandemic: An Evaluation of the South African Surveillance System |
Chenoa Sankar, Stephen Evans, Johanna Catharina Meyer, Hannah May Gunter, Victoria Sekiti, Kerrigan McCarthy |
| 2 |
[GO] |
2025―Mrz―12 |
Off-the-Shelf Large Language Models for Causality Assessment of Individual Case Safety Reports: A Proof-of-Concept with COVID-19 Vaccines |
Andrea Abate, Elisa Poncato, Maria Antonietta Barbieri, Greg Powell, Andrea Rossi, Simay Peker, Anders Hviid, Andrew Bate, Maurizio Sessa |
| 3 |
[GO] |
2025―Jan―22 |
Empowering African Expertise: Enhancing Safety Data Integration and Signal Detection for COVID-19 Vaccines Through the African Union Smart Safety Surveillance Joint Signal Management Group |
Victoria Prudence Nambasa, Hannah May Gunter, Modupe Bamidele Adeyemo, Neetesh Yanish Bhawaneedin, Marc Blockman, George Tsey Sabblah, John Owusu Gyapong, Eric Muriithi Guantai, Tamrat Abebe, Workeabeba Abebe, Henry Jeremy Lawson, Mercedes Chawada Leburu, Abdullahi Mohammed, Kwame Amponsa-Achiano, Mafora Florah Matlala, Uchenna Geraldine Elemuwa, Hudu Mogtari, Alexander Kwadwo Nyarko, Marione Schönfeldt, Mercy Kamupira, Kerrigan McCarthy, Yohannes Lakew Tefera, Asnakech Alemu, Kabir Mawashi Yusuf, Obi Emelife, Ladji Sidibe, Kudakwashe Dandajena, Kenneth Onu, Mojisola Christianah Adeyeye, Delese Mimi Darko, Heran Gerba, Boitumelo Semete, Fred Siyoi, Aggrey Ambali, Johanna Catharina Meyer |
| 4 |
[GO] |
2025―Jan―10 |
Multi-Stakeholder Call to Action for the Future of Vaccine Post-Marketing Monitoring: Proceedings from the First Beyond COVID-19 Monitoring Excellence (BeCOME) Conference |
Vincent Bauchau, Kaatje Bollaerts, Phil Bryan, Jim Buttery, Kourtney Davis, Robert T. Chen, Daniel R. Feikin, Antonella Fretta, Sarah Frise, Sonja Gandhi-Banga, Hector S. Izurieta, Corinne Jouquelet-Royer, Alena Khromava, Lin Li, Raj Long, Sarah MacDonald, Lydie Marcelon, Robert Massouh, Wilhelmine Meeraus, Flor M. Munoz, Karen Naim, Dale Nordenberg, Hanna Nohynek, Heather Rubino, Daniel A. Salmon, Sarah Sellers, Laurence Serradell, Laurence Torcel-Pagnon, Jamie Wilkins |
| 5 |
[GO] |
2024―Dez―05 |
Early Detection of Hearing Impairment Signals Post-mRNA COVID-19 Vaccination: A Disproportionality Analysis Study on French Pharmacovigilance Database |
Dalil Boulefaa, Haleh Bagheri, Francesco Salvo, Marie-Blanche Rabier, Hélène Geniaux, Marion Lepelley, Fanny Rocher, Julien Mahe, Aurélie Grandvillemuin, Hung Thai-Van |
| 6 |
[GO] |
2024―Jul―27 |
Acute Appendicitis After COVID-19 Vaccines in Italy: A Self-Controlled Case Series Study |
Cristina Morciano, Marco Massari, Maria Cutillo, Valeria Belleudi, Gianluca Trifirò, Nadia Mores, Ester Sapigni, Aurora Puccini, Giovanna Zanoni, Manuel Zorzi, Giuseppe Monaco, Olivia Leoni, Stefania Del Zotto, Sarah Samez, Flavia Mayer, Giuseppe Marano, Francesca Menniti Ippolito, Roberto Da Cas, Giuseppe Traversa, Stefania Spila Alegiani |
| 7 |
[GO] |
2024―Jul―15 |
Safety and Effectiveness of COVID-19 Vaccines During Pregnancy: A Living Systematic Review and Meta-analysis |
Agustín Ciapponi, Mabel Berrueta, Fernando J. Argento, Jamile Ballivian, Ariel Bardach, Martin E. Brizuela, Noelia Castellana, Daniel Comandé, Sami Gottlieb, Beate Kampmann, Agustina Mazzoni, Edward P. K. Parker, Juan M. Sambade, Katharina Stegelmann, Xu Xiong, Andy Stergachis, Pierre Buekens |
| 8 |
[GO] |
2024―Jun―22 |
What is the Safety of COVID-19 Vaccines in Immunocompromised Patients? Results from the European “Covid Vaccine Monitor” Active Surveillance Study |
Chiara Bellitto, Nicoletta Luxi, Francesco Ciccimarra, Luca L’Abbate, Monika Raethke, Florence van Hunsel, Thomas Lieber, Erik Mulder, Fabio Riefolo, Felipe Villalobos, Nicolas H. Thurin, Francisco B. Marques, Kathryn Morton, Fergal O’Shaughnessy, Simona Sonderlichová, Andreea Farcas, Giele-Eshuis Janneke, Miriam C. Sturkenboom, Gianluca Trifirò |
| 9 |
[GO] |
2024―Mai―13 |
Long-Term Safety Analysis of the BBV152 Coronavirus Vaccine in Adolescents and Adults: Findings from a 1-Year Prospective Study in North India |
Upinder Kaur, Aakanksha Jaiswal, Ayushi Jaiswal, Kunal Singh, Aditi Pandey, Mayank Chauhan, Mahek Rai, Sangeeta Kansal, Kishor Patwardhan, Vaibhav Jaisawal, Sankha Shubhra Chakrabarti |
| 10 |
[GO] |
2024―Mai―10 |
Use of Sotrovimab in Pregnancy: Experiences from the COVID-19 International Drug Pregnancy Registry |
Diego F. Wyszynski, Lydia Demetriou, Cheryl Renz, Shirin Aliabadi, Dragutin Rafailovic, Lee P. Shulman, Myriam Drysdale, Keele E. Wurst |
| 11 |
[GO] |
2024―Apr―12 |
COVID-19 Vaccines and Heavy Menstrual Bleeding: The Impact of Media Attention on Reporting to EudraVigilance |
María Gordillo-Marañón, Agnieszka Szmigiel, Vladimíra Yalmanová, Irina Caplanusi, Georgy Genov, David Benee Olsen, Sabine Straus |
| 12 |
[GO] |
2024―Feb―27 |
Safety of Simultaneous Administration of Bivalent mRNA COVID-19 and Influenza Vaccines in the Vaccine Adverse Event Reporting System (VAERS) |
Pedro L. Moro, Carol Ennulat, Hannah Brown, Gina Woody, Bicheng Zhang, Paige Marquez, Emily Jane Woo, John R. Su |
| 13 |
[GO] |
2024―Feb―23 |
The Role of the European Medicines Agency in the Safety Monitoring of COVID-19 Vaccines and Future Directions in Enhancing Vaccine Safety Globally |
Irina Caplanusi, Agnieszka Szmigiel, Menno van der Elst, Marie Louise Schougaard Christiansen, Steffen Thirstrup, Cosimo Zaccaria, Bénédicte Cappelli, Georgy Genov, Sabine Straus |
| 14 |
[GO] |
2023―Dez―12 |
Effectiveness and Respiratory Adverse Events Following Inactivated and mRNA COVID-19 Vaccines in Patients with COPD and Asthma: A Chinese Population-Based Study |
Simon Xiwen Qin, Franco Wing Tak Cheng, Wang Chun Kwok, Lydia W. Y. Fung, Tian Tian Ma, Hei Hang Edmund Yiu, Chloe Bloom, Christine F. McDonald, Ching-Lung Cheung, Francisco Tsz Tsun Lai, Celine Sze Ling Chui, Xue Li, Carlos King Ho Wong, Eric Yuk Fai Wan, Ian Chi Kei Wong, Esther Wai Yin Chan |
| 15 |
[GO] |
2023―Dez―07 |
Optimizing Signal Management in a Vaccine Adverse Event Reporting System: A Proof-of-Concept with COVID-19 Vaccines Using Signs, Symptoms, and Natural Language Processing |
Guojun Dong, Andrew Bate, François Haguinet, Gabriel Westman, Luise Dürlich, Anders Hviid, Maurizio Sessa |
| 16 |
[GO] |
2023―Nov―16 |
The COVID-19 International Drug Pregnancy Registry (COVID-PR): Protocol Considerations |
Diego F. Wyszynski, Aris T. Papageorghiou, Cheryl Renz, Torri D. Metz, Sonia Hernández-Díaz |
| 17 |
[GO] |
2023―Nov―05 |
Impact of Covid-19 Vaccination on Spontaneous Pharmacovigilance Reporting in France |
Sibylle de Germay, Allison Singier, Francesco Salvo, Antoine Pariente |
| 18 |
[GO] |
2023―Sep―14 |
An Exploratory Study of the Impact of COVID-19 Vaccine Spontaneous Reporting on Masking Signal Detection in EudraVigilance |
Benjamin Micallef, Jean-Michel Dogné, Janet Sultana, Sabine M. J. M. Straus, Robert Nisticò, Anthony Serracino-Inglott, John-Joseph Borg |
| 19 |
[GO] |
2023―Aug―09 |
Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand |
Muireann Walton, Vadim Pletzer, Thomas Teunissen, Thomas Lumley, Timothy Hanlon |
| 20 |
[GO] |
2023―Apr―27 |
Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials |
Fariba Ahmadizar, Nicoletta Luxi, Monika Raethke, Sandor Schmikli, Fabio Riefolo, Putri Widi Saraswati, Camelia Bucsa, Alhadi Osman, Megan Liddiard, Francisco Batel Maques, Giuliana Petrelli, Simona Sonderlichová, Nicolas H. Thurin, Felipe Villalobos, Gianluca Trifirò, Miriam Sturkenboom, Ugo Moretti, Chiara Bellitto, Francesco Ciccimarra, Laura Augusta Gonella, Elena Arzenton, Cristiano Chiamulera, Riccardo Lora, David Bellantuono, Alberto Sabaini, Alberto Firenze, Donatella Zodda, Fabrizia Guidotti, Maria Zappone, Bernardo Alagna, Paola Maria Cutroneo, Claudia Minore, Claudio Costantino, Francesco Vitale, G. D’Alessandro, Ilaria Morreale, Laura Marsala, Desirè Farinella, Silvana Bavetta, Maria Pia Fantini, Chiara Reno, Emanuel Raschi, Elisabetta Poluzzi, Ester Sapigni, Anna Maria Potenza, Debora Podetti, Victoria Nikitina, Rita Ricciardelli, Nazanin Mogheiseh, Silvia Croce, Barbara Paltrinieri, Sofia Castellani, Elisa Sangiorgi, Margherita Selleri, Simona Lucchesi, Giuseppe Catucci, Denis Savini, Chiara Sacripanti, Marco Faccioli, Maria Silvia Romio, Laura Rossi, Simonetta Radici, Giovanna Negri, Lidia Fares, Chiara Ajolfi, Antonella Fadda, Antonella Chiarello, Fabio Pieraccini, Barbara Gavioli, Simonetta Palazzi, Marco Tuccori, Alfredo Vannacci, Roberto Bonaiuti, Claudia Ravaldi, Niccolò Lombardi, Giada Crescioli, Francesco Gori, Roberto Tessari, Emanuela Zandonà, Giovanna Zanoni, Gianenrico Senna, Maria Angiola Crivellaro, Mauro Cancian, Francesca Venturini, Marina Ferri, Luca Leonardi, Sabrina Orzetti, Elisabetta Caccin, Paolo Baldo, Annalisa Capuano, Concetta Rafaniello, Carmen Ferrajolo, Claudia Pagliaro, Mariangela Mercaldo, Annalisa di Giorgio, Michele Tari, Sonia Manna, Giuseppina Farina, Cristina Di Mauro, Ilenia De Carlo, Ilenia Senesi, Claudia Pileggi, Caterina Palleria, Luca Gallelli, Giovambattista De Sarro, Caterina de Sarro, Chiara Verduci, Rosa Papadopoli, Luigia Trabace, Mariagrazia Morgese, Stefania Schiavone, Paolo Tucci, Maria Bove, Francesco Lapi, Claudio Cricelli, Giorgio Racagni, Silvia Tonolo, Giusi Fava, Sandro Giuffrida, Vincenza Amato, Marco Gambera, Valentina Montresor, Dario Mastropasqua |
| 21 |
[GO] |
2023―Apr―23 |
Quality of MedDRA® Coding in a Sample of COVID-19 Vaccine Medication Error Data |
Katarina Kralova, Carol-Ann Wilson, Nicolas Richebourg, Joan D’souza |
| 22 |
[GO] |
2023―Apr―11 |
Real-World Monitoring of COVID-19 Vaccines: An Industry Expert View on the Successes, Challenges, and Future Opportunities |
Vincent Bauchau, Kourtney Davis, Sarah Frise, Corinne Jouquelet-Royer, Jamie Wilkins |
| 23 |
[GO] |
2023―Apr―07 |
Cohort Event Monitoring of Adverse Reactions to COVID-19 Vaccines in Seven European Countries: Pooled Results on First Dose |
Monika Raethke, Florence van Hunsel, Nicolas H. Thurin, Caroline Dureau-Pournin, Dirk Mentzer, Barbara Kovačić, Nikica Mirošević Skvrce, Evelien De Clercq, Martine Sabbe, Gianluca Trifirò, Nicoletta Luxi, Alexia Giovanazzi, Saad Shakir, Olaf H. Klungel, Sandor Schmikli, Miriam Sturkenboom |
| 24 |
[GO] |
2023―Feb―22 |
Adverse Events to SARS-CoV-2 (COVID-19) Vaccines and Policy Considerations that Inform the Funding of Safety Surveillance in Low- and Middle-Income Countries: A Mixed Methods Study |
Comfort K. Ogar, Jonathan Quick, Hannah N. Gilbert, Rick A. Vreman, Aukje K. Mantel-Teeuwisse, Jean Claude Mugunga |
| 25 |
[GO] |
2023―Feb―14 |
Optimizing Safety Surveillance for COVID-19 Vaccines at the Swedish Medical Products Agency |
Karl Mikael Kälkner, Anders Sundström, Marja-Leena Nurminen, Maria Larsson, Rickard Ljung, Veronica Arthurson |
| 26 |
[GO] |
2023―Jan―22 |
The COVID-19 Vaccines International Pregnancy Exposure Registry (C-VIPER): Protocol and Methodological Considerations |
Diego F. Wyszynski, Mondira Bhattacharya, Oscar Martínez-Pérez, Anthony R. Scialli, Melissa Tassinari, Naor Bar-Zeev, Cheryl Renz, Sonia Hernández-Díaz |
| 27 |
[GO] |
2022―Dez―23 |
Effect of Previous Anticoagulant Treatment on Risk of COVID-19 |
Maruxa Zapata-Cachafeiro, Ángela Prieto-Campo, Manuel Portela-Romero, Eduardo Carracedo-Martínez, Martina Lema-Oreiro, María Piñeiro-Lamas, Somnath Chaudhuri, Ángel Salgado-Barreira, Adolfo Figueiras |
| 28 |
[GO] |
2022―Dez―02 |
The Food and Drug Administration’s (FDA’s) Drug Safety Surveillance During the COVID-19 Pandemic |
Ida-Lina Diak, Kimberley Swank, Kate McCartan, Maya Beganovic, James Kidd, Neha Gada, Rachna Kapoor, Lisa Wolf, Laura Kangas, Jo Wyeth, Toni Salvatore, Melina Fanari, Andrew A. LeBoeuf, Poonam Mishra, Michael D. Blum, Gerald Dal Pan |
| 29 |
[GO] |
2022―Nov―09 |
Optimizing Safety Surveillance for COVID-19 Vaccines at the National Pharmacovigilance Centre Lareb: One Year of COVID-19 Vaccine Experience |
Ingrid Oosterhuis, Joep Scholl, Eugène van Puijenbroek, Agnes Kant, Florence van Hunsel |
| 30 |
[GO] |
2022―Okt―02 |
mRNA (BNT162b2) and Inactivated (CoronaVac) COVID-19 Vaccination and Risk of Adverse Events and Acute Diabetic Complications in Patients with Type 2 Diabetes Mellitus: A Population-Based Study |
Eric Yuk Fai Wan, Celine Sze Ling Chui, Anna Hoi Ying Mok, Wanchun Xu, Vincent Ka Chun Yan, Francisco Tsz Tsun Lai, Xue Li, Carlos King Ho Wong, Esther Wai Yin Chan, David Tak Wai Lui, Kathryn Choon Beng Tan, Ivan Fan Ngai Hung, Cindy Lo Kuen Lam, Gabriel Matthew Leung, Ian Chi Kei Wong |
| 31 |
[GO] |
2022―Sep―03 |
Correction to: Assessing Case Fatality on Cases of Thrombosis with Concurrent Thrombocytopenia Following COVID-19 Vaccine AstraZeneca (Vaxzevria) in the United Kingdom: A Review of Spontaneously Reported Data |
Samantha Lane, Saad Shakir |
| 32 |
[GO] |
2022―Aug―27 |
A Prospective Observational Study on BBV152 Coronavirus Vaccine Use in Adolescents and Comparison with Adults: Interim Results of the First Real-World Safety Analysis |
Upinder Kaur, Anju K.L, Mayank Chauhan, Aditi Joshi, Agniva Das, Sangeeta Kansal, Vaibhav Jaisawal, Kishor Patwardhan, Sankha Shubhra Chakrabarti |
| 33 |
[GO] |
2022―Aug―04 |
Assessing Case Fatality on Cases of Thrombosis with Concurrent Thrombocytopenia Following COVID-19 Vaccine AstraZeneca (Vaxzevria) in the United Kingdom: A Review of Spontaneously Reported Data |
Samantha Lane, Saad Shakir |
| 34 |
[GO] |
2022―Jul―15 |
Authors’ Reply to Mungmunpuntipantip et al.’s Comment on “Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands” |
Agnes Kant, Florence van Hunsel |
| 35 |
[GO] |
2022―Jul―15 |
Comment on “Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands” |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
| 36 |
[GO] |
2022―Jun―23 |
Signaling COVID-19 Vaccine Adverse Events |
Rave Harpaz, William DuMouchel, Robbert Van Manen, Alexander Nip, Steve Bright, Ana Szarfman, Joseph Tonning, Magnus Lerch |
| 37 |
[GO] |
2022―Mrz―21 |
Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands |
Agnes Kant, Jurriaan Jansen, Leontine van Balveren, Florence van Hunsel |
| 38 |
[GO] |
2022―Jan―22 |
Spontaneous Reporting to Regulatory Authorities of Suspected Adverse Drug Reactions to COVID-19 Vaccines Over Time: The Effect of Publicity |
Robin E. Ferner, Richard J. Stevens, Christopher Anton, Jeffrey K. Aronson |
| 39 |
[GO] |
2021―Nov―05 |
COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety |
Nicoletta Luxi, Alexia Giovanazzi, Annalisa Capuano, Salvatore Crisafulli, Paola Maria Cutroneo, Maria Pia Fantini, Carmen Ferrajolo, Ugo Moretti, Elisabetta Poluzzi, Emanuel Raschi, Claudia Ravaldi, Chiara Reno, Marco Tuccori, Alfredo Vannacci, Giovanna Zanoni, Gianluca Trifirò, Gianluca Trifirò, Ugo Moretti, Nicoletta Luxi, Alexia Giovanazzi, Giuliana Petrelli, Silvia Girotti, Elena Arzenton, Lara Magro, Riccardo Lora, David Bellantuono, Alberto Sabaini, Alberto Firenze, Donatella Zodda, Fabrizia Guidotti, Maria Zappone, Bernardo Alagna, Edoardo Spina, Paola Maria Cutroneo, Claudia Minore, Claudio Costantino, Arianna Conforto, Francesco Vitale, Ilaria Morreale, Laura Marsala, Desirè Farinella, Silvana Bavetta, Emanuel Raschi, Elisabetta Poluzzi, Maria Pia Fantini, Chiara Reno, Ester Sapigni, Anna Maria Potenza, Debora Podetti, Victoria Nikitina, Rita Ricciardelli, Nazanin Mogheiseh, Silvia Croce, Barbara Paltrinieri, Sofia Castellani, Elisa Sangiorgi, Margherita Selleri, Simona Lucchesi, Giuseppe Catucci, Denis Savini, Chiara Sacripanti, Marco Faccioli, Maria Silvia Romio, Laura Rossi, Simonetta Radici, Giovanna Negri, Lidia Fares, Chiara Ajolfi, Antonella Fadda, Antonella Chiarello, Fabio Pieraccini, Francesco Pappalardo, Marco Tuccori, Alfredo Vannacci, Roberto Bonaiuti, Claudia Ravaldi, Niccolò Lombardi, Giada Crescioli, Roberto Tessari, Emanuela Zandonà, Francesco Marchiori, Cristiano Chiamulera, Giovanna Zanoni, Gianenrico Senna, Maria Angiola Crivellaro, Mauro Cancian, Francesca Venturini, Marina Ferri, Luca Leonardi, Sabrina Orzetti, Elisabetta Caccin, Paolo Baldo, Annalisa Capuano, Concetta Rafaniello, Carmen Ferrajolo, Claudia Pagliaro, Mariangela Mercaldo, Annamaria Fucile, Annalisa di Giorgio, Michele Tari, Sonia Manna, Giuseppina Farina, Cristina Di Mauro, Ilenia De Carlo, Ilenia Senesi, Claudia Pileggi, Caterina Palleria, Luca Gallelli, Giovambattista De Sarro, Luigia Trabace, Mariagrazia Morgese, Stefania Schiavone, Paolo Tucci, Maria Bove, Francesco Lapi, Claudio Cricelli, Giorgio Racagni, Silvia Tonolo, Eugenio Leopardi, Giusi Fava, Sandro Giuffrida, Vincenza Amato, Marco Gambera, Valentina Montresor |
| 40 |
[GO] |
2021―Aug―17 |
Inconsistent Safety Outcome Reporting in Randomized Clinical Trials of COVID-19 Vaccines Complicates Informed Medical Decisions |
Joseph E. Blais, Yue Wei, Celine S. L. Chui, Esther W. Chan, Ian C. K. Wong |
| 41 |
[GO] |
2021―Aug―10 |
Remdesivir in the COVID-19 Pandemic: An Analysis of Spontaneous Reports in VigiBase During 2020 |
Elena Rocca, Oskar Gauffin, Ruth Savage, Sara Hedfors Vidlin, Birgitta Grundmark |
| 42 |
[GO] |
2021―Aug―04 |
Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month Report |
Toyotaka Iguchi, Hikari Umeda, Michie Kojima, Yuri Kanno, Yuta Tanaka, Natsumi Kinoshita, Daisaku Sato |
| 43 |
[GO] |
2021―Aug―02 |
NSAIDs and COVID-19: A Systematic Review and Meta-analysis |
Nicholas Moore, Pauline Bosco-Levy, Nicolas Thurin, Patrick Blin, Cécile Droz-Perroteau |
| 44 |
[GO] |
2021―Apr―16 |
Safety and Efficacy of Ivermectin and Doxycycline Monotherapy and in Combination in the Treatment of COVID-19: A Scoping Review |
Subhrojyoti Bhowmick, Amit Dang, B. N. Vallish, Sumit Dang |
| 45 |
[GO] |
2021―Mrz―05 |
Safety Consequences of Off-Label Drugs Used for COVID-19 |
Nabarun Dasgupta |
| 46 |
[GO] |
2021―Feb―19 |
Correction to: Assessing the Safety of COVID-19 Vaccines: A Primer |
Helen Petousis-Harris |
| 47 |
[GO] |
2020―Dez―28 |
French Pharmacovigilance Public System and COVID-19 Pandemic |
Aurélie Grandvuillemin, Milou-Daniel Drici, Annie Pierre Jonville-Bera, Joelle Micallef, Jean Louis Montastruc |
| 48 |
[GO] |
2020―Dez―22 |
Global Safety Database Summary of COVID-19-Related Drug Utilization-Safety Surveillance: A Sponsor’s Perspective |
Elena Beyzarov, Yan Chen, Rob Julg, Karen Naim, Jigna Shah, William W. Gregory, Ayman Ayoub, Patrick Caubel |
| 49 |
[GO] |
2020―Nov―27 |
Sex Differences in Lopinavir Concentrations and Occurrence of Marked QTc Prolongation Episodes in Patients with COVID-19 |
Catia Marzolini, Felix Stader, Anne Leuppi-Taegtmeyer, Marcel Stoeckle, Manuel Battegay, Parham Sendi |
| 50 |
[GO] |
2020―Nov―21 |
How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine |
Saad Shakir, Samantha Lane, Miranda Davies |
| 51 |
[GO] |
2020―Okt―19 |
Psychiatric Disorders and Hydroxychloroquine for Coronavirus Disease 2019 (COVID-19): A VigiBase Study |
Philippe Garcia, Alexis Revet, Antoine Yrondi, Vanessa Rousseau, Yannick Degboe, François Montastruc |
| 52 |
[GO] |
2020―Sep―30 |
Assessing the Safety of COVID-19 Vaccines: A Primer |
Helen Petousis-Harris |
| 53 |
[GO] |
2020―Sep―25 |
Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports |
Alem Zekarias, Sarah Watson, Sara Hedfors Vidlin, Birgitta Grundmark |
| 54 |
[GO] |
2020―Aug―27 |
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients |
Gianluca Trifirò, Marco Massari, Roberto Da Cas, Francesca Menniti Ippolito, Janet Sultana, Salvatore Crisafulli, Paolo Giorgi Rossi, Massimiliano Marino, Manuel Zorzi, Emanuela Bovo, Olivia Leoni, Monica Ludergnani, Stefania Spila Alegiani |
| 55 |
[GO] |
2020―Jul―21 |
Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines |
Janet Sultana, Paola Maria Cutroneo, Salvatore Crisafulli, Gabriele Puglisi, Gaetano Caramori, Gianluca Trifirò |
| 56 |
[GO] |
2020―Jun―23 |
Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment |
Vicki Osborne, Miranda Davies, Samantha Lane, Alison Evans, Jacqueline Denyer, Sandeep Dhanda, Debabrata Roy, Saad Shakir |
| 57 |
[GO] |
2020―Jun―22 |
The Impact of the COVID-19 “Infodemic” on Drug-Utilization Behaviors: Implications for Pharmacovigilance |
Marco Tuccori, Irma Convertino, Sara Ferraro, Emiliano Cappello, Giulia Valdiserra, Daniele Focosi, Corrado Blandizzi |
| 58 |
[GO] |
2020―Jun―11 |
Does Ibuprofen Worsen COVID-19? |
Nicholas Moore, Bruce Carleton, Patrick Blin, Pauline Bosco-Levy, Cecile Droz |
| 59 |
[GO] |
2020―Jun―08 |
Drug-Induced Liver Injury and COVID-19 Infection: The Rules Remain the Same |
Alexandre Olry, Lucy Meunier, Bénédicte Délire, Dominique Larrey, Yves Horsmans, Hervé Le Louët |
| 60 |
[GO] |
2020―Mai―28 |
Remdesivir in Treatment of COVID-19: A Systematic Benefit-Risk Assessment |
Miranda Davies, Vicki Osborne, Samantha Lane, Debabrata Roy, Sandeep Dhanda, Alison Evans, Saad Shakir |
| 61 |
[GO] |
2020―Mai―07 |
The Role of Pharmacovigilance and ISoP During the Global COVID-19 Pandemic |
Rebecca E Chandler, Deirdre McCarthy, Jean-Christophe Delumeau, Mira Harrison-Woolrych |
| 62 |
[GO] |
2020―Apr―17 |
Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? |
Gianluca Trifirò, Salvatore Crisafulli, Giuseppe Andò, Giorgio Racagni, Filippo Drago |
| 63 |
[GO] |
2020―Apr―07 |
Chloroquine for COVID-19 Infection |
Nicholas Moore |
|
